Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - AlumiFuel Power Corpafpw8k2910ex99_1.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

Current Report Pursuant to Section 13 or
15(d) of the Securities Act of 1934



Date of Report (Date of earliest event reported):
February 4, 2010


ALUMIFUEL POWER CORPORATION
(Exact name of registrant as specified in its charter)


Nevada
333-57946
88-0448626
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification Number)


7315 East Peakview Avenue
Englewood, Colorado 80111
 (Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code: (303) 796-8940


 (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
Other Events.
 
On February 9, 2010, AlumiFuel Power Corporation issued a press release announcing that it had received a purchase order for three units of its PBIS-1000 Portable Balloon Inflation System.  The press release announcing this order is included as Exhibit 99.1 and incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.
 
(a)           Not applicable.

(b)           Not applicable.

(c)           Not applicable.
 
(d)           Exhibits.
 
Exhibit
Description
99.1
Press Release dated February 9, 2010 (filed herewith)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
INHIBITON THERAPEUTICS, INC.
 
Date:  February 9, 2010
By:           /s/  Thomas B. Olson 
Thomas B. Olson, Secretary